Cellomics Technology

Founded with a mission to advance gene engineering, Cellomics Technology LLC is a biotechnology company specializing in lentivirus production, gene targeting, stable cell line generation, gene cloning, and DNA mutagenesis. The company is dedicated to developing innovative tools for mammalian cell gene engineering, including gene knockout, knockdown, and overexpression. Their products and custom services cater to both somatic and stem cell genetic engineering, aiming to accelerate research in these fields.

Cellomics Technology has garnered attention for its scientific excellence and impactful contributions to biotechnology. The company collaborates with leading researchers and institutions to push the boundaries of genetic engineering. Notable achievements include the development of highly effective lentiviral vectors for gene delivery into hard-to-transfect cells like T cells and neurons. Through these advancements, Cellomics Technology is significantly impacting the field of genetic research and therapy.